Bellevue Group AG Q2 2016 Filing
Filed August 12, 2016
Portfolio Value
$531.5B
Holdings
124
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (124 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MDTMedtronic, Inc. | 282,500 | $24.5B | 4.61% | |
| 2 | SYKStryker Corporation | 177,000 | $21.2B | 3.99% | |
| 3 | CELGCelgene Corporation | 196,050 | $19.3B | 3.64% | |
| 4 | ABTAbbott Laboratories | 381,500 | $15.0B | 2.82% | |
| 5 | CAHCardinal Health, Inc. | 188,780 | $14.7B | 2.77% | |
| 6 | UNHUnitedHealth Group Incorporated | 99,200 | $14.0B | 2.64% | |
| 7 | BIIBBiogen Inc. | 54,500 | $13.2B | 2.48% | |
| 8 | GILDGilead Sciences, Inc. | 156,500 | $13.1B | 2.46% | |
| 9 | ILMNIllumina, Inc. | 91,575 | $12.9B | 2.42% | |
| 10 | AMGNAmgen Inc. | 83,500 | $12.7B | 2.39% | |
| 11 | BSXBoston Scientific Corporation | 500,000 | $11.7B | 2.20% | |
| 12 | TEVATeva Pharmaceuticals Industries Ltd | 229,190 | $11.5B | 2.17% | |
| 13 | JAZZJazz Pharmaceuticals Public Limited Company | 75,300 | $10.6B | 2.00% | |
| 14 | REGNRegeneron Pharmaceuticals, Inc. | 30,000 | $10.5B | 1.97% | |
| 15 | ZBHZimmer Biomet Holdings, Inc. | 86,200 | $10.4B | 1.95% | |
| 16 | BDXBecton, Dickinson and Company | 59,000 | $10.0B | 1.88% | |
| 17 | —Auris Medical Holding AG | 2,169,625 | $9.1B | 1.71% | |
| 18 | LGNDLigand Pharmaceuticals Incorporated | 71,030 | $8.5B | 1.59% | |
| 19 | CNCCentene Corporation | 117,380 | $8.4B | 1.58% | |
| 20 | HOLXHologic, Inc. | 238,300 | $8.2B | 1.55% | |
| 21 | —Allergan PLC | 35,100 | $8.1B | 1.53% | |
| 22 | ISRGIntuitive Surgical, Inc. | 12,000 | $7.9B | 1.49% | |
| 23 | CVSCVS Health Corporation | 79,800 | $7.6B | 1.44% | |
| 24 | BAXBaxter International Inc. | 166,000 | $7.5B | 1.41% | |
| 25 | INCYIncyte Corporation | 91,000 | $7.3B | 1.37% | |
| 26 | —Shire PLC | 38,850 | $7.2B | 1.35% | |
| 27 | EWEdwards Lifesciences Corporation | 68,000 | $6.8B | 1.28% | |
| 28 | ABMDEURAbiomed Inc | 57,200 | $6.3B | 1.18% | |
| 29 | CICigna Corporation | 48,000 | $6.1B | 1.16% | |
| 30 | JNJJohnson & Johnson | 50,000 | $6.1B | 1.14% | |
| 31 | BCRUSDC.R. Bard, Inc. | 25,000 | $5.9B | 1.11% | |
| 32 | ALXNAlexion Pharmaceuticals, Inc. | 49,400 | $5.8B | 1.09% | |
| 33 | —Amsurg Corp | 74,000 | $5.7B | 1.08% | |
| 34 | VRTXVertex Pharmaceuticals Incorporated | 66,000 | $5.7B | 1.07% | |
| 35 | HUMHumana, Inc. | 30,000 | $5.4B | 1.02% | |
| 36 | —Mylan Inc. | 119,700 | $5.2B | 0.97% | |
| 37 | CHRSCoherus BioSciences, Inc | 304,000 | $5.1B | 0.97% | |
| 38 | BMRNBioMarin Pharmaceutical Inc. | 65,000 | $5.1B | 0.95% | |
| 39 | —Express Scripts Holding Company | 65,000 | $4.9B | 0.93% | |
| 40 | MCKMcKesson Corporation | 26,000 | $4.9B | 0.91% | |
| 41 | —Medivation, Inc. | 78,000 | $4.7B | 0.88% | |
| 42 | —St. Jude Medical, Inc. | 60,000 | $4.7B | 0.88% | |
| 43 | COOCooper Companies Inc. | 23,500 | $4.0B | 0.76% | |
| 44 | PRGOPerrigo Company plc | 44,000 | $4.0B | 0.75% | |
| 45 | 3M4Masimo Corporation | 75,000 | $3.9B | 0.74% | |
| 46 | —ARIAD Pharmaceuticals, Inc. | 495,000 | $3.7B | 0.69% | |
| 47 | —Akorn Inc | 127,000 | $3.6B | 0.68% | |
| 48 | NUVAGBPNuvasive, Inc. | 60,000 | $3.6B | 0.67% | |
| 49 | CERNCHFCerner Corporation | 60,000 | $3.5B | 0.66% | |
| 50 | HCAHCA Holdings, Inc. | 43,700 | $3.4B | 0.63% | |
| 51 | SUPNSupernus Pharmaceuticals, Inc. | 164,000 | $3.3B | 0.63% | |
| 52 | —Achillion Pharmaceuticals, Inc. | 420,000 | $3.3B | 0.62% | |
| 53 | —Aetna Inc. | 25,900 | $3.2B | 0.60% | |
| 54 | TMOThermo Fisher Scientific Inc. | 20,000 | $3.0B | 0.56% | |
| 55 | —Mallinckrodt Pub Ltd Co. | 47,000 | $2.9B | 0.54% | |
| 56 | ALKSAlkermes Public Limited Company | 65,500 | $2.8B | 0.53% | |
| 57 | LLYLilly Eli & Co. | 35,000 | $2.8B | 0.52% | |
| 58 | SGENEURSeattle Genetics, Inc. | 68,000 | $2.7B | 0.52% | |
| 59 | HALOHalozyme Therapeutics, Inc. | 318,000 | $2.7B | 0.52% | |
| 60 | —Impax Laboratories, Inc. | 95,000 | $2.7B | 0.52% | |
| 61 | MRKMerck & Co., Inc. | 47,000 | $2.7B | 0.51% | |
| 62 | —Novadaq Technologies Inc. | 270,000 | $2.7B | 0.50% | |
| 63 | —Intersect Ent, Inc. | 205,325 | $2.7B | 0.50% | |
| 64 | NKTREURNektar Therapeutics | 186,000 | $2.6B | 0.50% | |
| 65 | NBIXNeurocrine Biosciences, Inc. | 58,000 | $2.6B | 0.50% | |
| 66 | ISIIonis Pharmaceuticals Inc. | 108,000 | $2.5B | 0.47% | |
| 67 | NVAXNovavax, Inc. | 325,000 | $2.4B | 0.44% | |
| 68 | MGNXMacrogenics, Inc. | 83,000 | $2.2B | 0.42% | |
| 69 | IBBiSHARES Trust | 8,500 | $2.2B | 0.41% | |
| 70 | ANGOAngioDynamics, Inc. | 151,400 | $2.2B | 0.41% | |
| 71 | GMEDGlobus Medical, Inc. | 87,700 | $2.1B | 0.39% | |
| 72 | QGENQiagen NV | 91,500 | $2.0B | 0.38% | |
| 73 | —Horizon Pharma plc | 117,000 | $1.9B | 0.36% | |
| 74 | ICPTUSDIntercept Pharmaceuticals, Inc. | 13,500 | $1.9B | 0.36% | |
| 75 | ELVAnthem, Inc. | 14,000 | $1.8B | 0.35% | |
| 76 | TFXTeleflex Incorporated | 10,010 | $1.8B | 0.33% | |
| 77 | PFEPfizer Inc. | 50,000 | $1.8B | 0.33% | |
| 78 | BMYBristol-Myers Squibb Company | 23,000 | $1.7B | 0.32% | |
| 79 | VAREURVarian Medical Systems, Inc. | 20,000 | $1.6B | 0.31% | |
| 80 | —Zeltiq Aesthetics Inc. | 60,000 | $1.6B | 0.31% | |
| 81 | HCSGHealthcare Services Group Inc. | 38,100 | $1.6B | 0.30% | |
| 82 | LABUUSDDirexion SHS ETF TR | 55,175 | $1.6B | 0.29% | |
| 83 | AGIOAgios Pharmaceuticals, Inc. | 36,000 | $1.5B | 0.28% | |
| 84 | —Radius Health Inc. | 40,000 | $1.5B | 0.28% | |
| 85 | ACADAcadia Pharmaceuticals, Inc. | 45,000 | $1.5B | 0.27% | |
| 86 | INOInovio Pharmaceuticals, Inc. | 155,000 | $1.4B | 0.27% | |
| 87 | —Juno Therapeutics, Inc. | 37,000 | $1.4B | 0.27% | |
| 88 | RAREUltragenyx Pharmaceuticals Inc. | 28,000 | $1.4B | 0.26% | |
| 89 | ALNYAlnylam Pharmaceuticals Inc. | 24,000 | $1.3B | 0.25% | |
| 90 | EX9Exelixis, Inc. | 170,000 | $1.3B | 0.25% | |
| 91 | —Bluebird Bio, Inc. | 29,000 | $1.3B | 0.24% | |
| 92 | —Alere Inc | 30,000 | $1.3B | 0.24% | |
| 93 | —Wright Med Group N V | 70,309 | $1.2B | 0.23% | |
| 94 | PRTAProthena Corporation plc | 31,000 | $1.1B | 0.20% | |
| 95 | —Laboratory Corporation of America Holdings | 8,000 | $1.0B | 0.20% | |
| 96 | —AAC Hldgs Inc | 45,000 | $1.0B | 0.19% | |
| 97 | DVADavita Healthcare Partners, Inc. | 13,000 | $1.0B | 0.19% | |
| 98 | —Envision Healthcare Hldgs Inc. | 39,000 | $989.0M | 0.19% | |
| 99 | ABBVAbbvie Inc. | 15,000 | $929.0M | 0.17% | |
| 100 | —Cepheid Inc. | 30,000 | $923.0M | 0.17% |
Page 1 of 2Next